Zobrazeno 1 - 10
of 25
pro vyhledávání: '"L. M. Zakhartseva"'
Autor:
L. M. Zakhartseva, O. P. Manzhura, I. Yu. Vashchenko, Ye. V. Maistrenko, O. M. Kravchuk, K. M. Shatrova, O. H. Rudnytska
Publikováno v:
Patologìâ, Vol 20, Iss 3, Pp 281-288 (2023)
Ovarian tumors constitute 3.4 % of the structure of oncological diseases in women worldwide. However, the ovaries are also a common target for metastasis of carcinoma from other organs. Conducting differential diagnosis between primary carcinoma and
Externí odkaz:
https://doaj.org/article/cda9fd72ca014e2c90f3e431429419ec
Autor:
L. M. Zakhartseva, H. Ye. Chytaieva
Publikováno v:
Patologìâ, Vol 18, Iss 3, Pp 254-262 (2021)
The aim of this study was to evaluate relations of mitotic index (MI), necrosis, IHC proliferative markers Ki-67 and PHH3, and their predictive value for lung neuroendocrine tumors (NETs) aggressiveness. Materials and methods. The study used surgi
Externí odkaz:
https://doaj.org/article/f7fcaf0fbecd4a89b33ee5ee6bccf83e
Autor:
L. M. Zakhartseva, M. O. Yanovytska
Publikováno v:
Patologìâ, Vol 17, Iss 3, Pp 287-294 (2020)
The aim of this retrospective study is to assess the prognostic value of tumor-infiltrating lymphocytes in triple negative breast carcinomas that lack both estrogen, progesterone receptors and Her2 amplification. The group of triple negative carci
Externí odkaz:
https://doaj.org/article/d8643e4f81014e0dadf28fa3b1c328e4
Publikováno v:
Східноукраїнський медичний журнал, Vol 8, Iss 1, Pp 15-23 (2020)
Introduction. Renal neoplasms are a common disease. Differential diagnostics of different tumor subtypes for prognosis and treatment is necessary given that some of them, like renal cell oncocytomas, are benign, and others, like chromophobe renal cel
Externí odkaz:
https://doaj.org/article/b8894926640b47d69e86d4803aa12338
Publikováno v:
Український журнал серцево-судинної хірургії, Iss 4 (37), Pp 23-27 (2019)
Abstract.The work is devoted to the results of the study of the role of the mitral valve (MV) in the pathogenesis of hypertrophic cardiomyopathy (HCM). Purpose. To determine the role of MV in the pathogenesis of HCM. Morphological examination was
Externí odkaz:
https://doaj.org/article/9f901282338e415daadd377bb2b382da
Publikováno v:
Art of Medicine. :58-63
The urgency of the problem is due to the high prevalence among the population in all countries of the world and socio-economic losses associated with serious complications of osteoporosis. Chronic non-gaseous acidosis leads to disruption of many meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::555696d729b02e1caf33433a7b7503fe
https://doi.org/10.21802/artm.2021.3.19.58
https://doi.org/10.21802/artm.2021.3.19.58
Publikováno v:
Experimental oncology. 44(2)
Metastases in eye structures are rare (1-5% cases at systemic spread of different malignancies, mainly breast and lung cancers). The prognosis is poor. The overall survival usually does not exceed 12 or even 6 months. If metastases are found in the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ad0b36feeaa8cd925494d570b1aca9d
https://pubmed.ncbi.nlm.nih.gov/35964644
https://pubmed.ncbi.nlm.nih.gov/35964644
Publikováno v:
Eastern Ukrainian Medical Journal. 8:15-23
Introduction. Renal neoplasms are a common disease. Differential diagnostics of different tumor subtypes for prognosis and treatment is necessary given that some of them, like renal cell oncocytomas, are benign, and others, like chromophobe renal cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5ba6f6a291be18af3759f1b7be5fa40
https://doi.org/10.21272/eumj.2020
https://doi.org/10.21272/eumj.2020
Publikováno v:
Український журнал серцево-судинної хірургії, Iss 4 (37), Pp 23-27 (2019)
The work is devoted to the results of the study of the role of the mitral valve (MV) in the pathogenesis of hypertrophic cardiomyopathy (HCM). Purpose. To determine the role of MV in the pathogenesis of HCM. Morphological examination was performed on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f666a1fc6ef4917a7419958fc390216
https://doi.org/10.30702/ujcvs/19.3712/074023-027
https://doi.org/10.30702/ujcvs/19.3712/074023-027
Autor:
N L Medvedieva, O E Lobanova, N.G. Gorovenko, Viktoriia Vershyhora, Z.I. Rossokha, R. Vereshchako, V. Cheshuk, L Ye Fishchuk, L M Zakhartseva
Publikováno v:
Experimental Oncology.
Background Recent advances in the treatment of breast cancer (BC) have been related to the personalization of therapy. The methylation status of the promoter regions of tumor suppressor genes such as BRCA1 and BRCA2 is supposed to be useful as a prog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fb84b318705f938925f998dab5a8115
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-1.15703
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-1.15703